HK Stock Market Move | FAMEGLOW (03774) surges over 28% as the company opens a new "medical aesthetics + AI" narrative, with rapid business expansion over the past three years.

FAMEGLOW (03774) surged over 28% intraday. On June 30 this year, FAMEGLOW successfully completed its transfer from GEM to the Main Board, and just over two months later officially entered the Stock Connect Southbound list. As of press time, the stock is up 23.31% at HK$36.50, with turnover of HK$52.2078 million. Public information shows that FAMEGLOW, as a medical aesthetics service provider, operates medical aesthetics centers under the "per Face" brand in prime locations in Hong Kong including Causeway Bay, Tsim Sha Tsui, Mong Kok and Central, as well as in Macau. Notably, the company is anchoring its strategic focus on the "AI + high-end biotech skincare" track. In July this year, FAMEGLOW launched the development of its "AI anti-aging" platform, engaging Hong Kong AI company Sunseeker to develop the model. The company has expanded rapidly over the past three years. For the years ended March 31, 2024, 2025 and 2026, the company's revenue was approximately HK$299 million, HK$435 million and HK$590 million, respectively, representing a compound annual growth rate of over 40%; net profit also rose steadily from approximately HK$41 million to HK$55 million. At the same time, its customer base has expanded significantly, with active customers increasing from approximately 13,000 in fiscal 2024 to approximately 24,000 in fiscal 2026, an increase of nearly onefold.